National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Helicobacter pylori (H. pylori) is a critical etiological agent in the pathogenesis of a wide range of gastroduodenal diseases, yet epidemiological data remain sparse in certain regions, including North Africa. This cross-sectional study assessed the prevalence and clinical significance of H. pylori among 144 dyspeptic patients undergoing upper gastrointestinal endoscopy at Benghazi Medical Center, Libya. A comprehensive diagnostic approach was employed, integrating serological (IgG), stool antigen, and urease tests, as well as PCR-based amplification of the 16S rRNA, GLM, and HPU genes. The overall H. pylori IgG seroprevalence was 72.2%, with stool antigen and rapid urease tests indicating active infection in 62.5% and 61.1% of patients, respectively, and molecular assays confirming H. pylori in over 60%. Notably, infection rates were disproportionately elevated in patients diagnosed with gastritis (45.8%) and peptic ulcer disease (18.1%), demonstrating a robust association between H. pylori positivity and these conditions. Furthermore, strains harboring specific virulence factors correlated with more severe clinical outcomes, underscoring the pathogen’s central role in disease progression. These findings highlight the urgent need for improved diagnostic strategies, locally tailored treatments, and targeted public health measures to mitigate the substantial disease burden imposed by H. pylori.
Al-Hosni, M., Alsheikh, M. A., and Elhasady, M. M. (2023). Prevalence of Helicobacter pylori infection in children and adolescents. African Journal of Advanced Pure and Applied Sciences, 2(1), 28–38.
Amieva, M., and Peek, R. M., Jr. (2016). Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology, 150(1), 64–78. https://doi.org/10.1053/j.gastro.2015.09.004
Asrat, D., Nilsson, I., Mengistu, Y., Ashenafi, S., Ayenew, K., Al-Soud, W. A., Wadström, T., and Kassa, E. (2004). Prevalence of Helicobacter pylori infection among adult dyspeptic patients in Ethiopia. Annals of Tropical Medicine and Parasitology, 98(2), 181–189. https://doi.org/10.1179/000349804225003190
Aviles-Jimenez, F. Vazquez-Jimenez, R. Medrano-Guzman, A. Mantilla, J. Torres. 2014. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci. Rep., 4 (1) (2014), pp. 1-11.
Basso, D., Navaglia, F., Brigato, L., Piva, M. G., Toma, A., Greco, E., Di Mario, F., Galeotti, F., Roveroni, G., Corsini, A., and Plebani, M. (1998). Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut, 43(2), 182–186.
https://doi.org/10.1136/gut.43.2.182
Cover, T. L., and Blanke, S. R. (2005). Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nature Reviews Microbiology, 3(4), 320–332.
https://doi.org/10.1038/nrmicro1095
Dixon, M. F., Genta, R. M., Yardley, J. H., and Correa, P. (1996). Classification and grading of gastritis: The updated Sydney System. American Journal of Surgical Pathology, 20(10), 1161–1181. https://doi.org/10.1097/00000478-199610000-00001
Eusebi, L. H., Zagari, R. M., and Bazzoli, F. (2014). Epidemiology of Helicobacter pylori infection. Helicobacter, 19(Suppl 1), 1–5. https://doi.org/10.1111/hel.12165
Forbes, B. A., Sahm, D. F., andWeissfeld, A. S. (1998). Bailey and Scott’s Diagnostic Microbiology (10th ed.). Mosby.
Goh, K. L., Chan, W. K., Shiota, S., and Yamaoka, Y. (2011). Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter, 16(Suppl 1), 1–9. https://doi.org/10.1111/j.1523-5378.2011.00874.x
Hatakeyama, M. (2014). Helicobacter pylori CagA and gastric cancer: A paradigm for hit-and-run carcinogenesis. Cell Host and Microbe, 15(3), 306–316. https://doi.org/10.1016/j.chom.2014.02.008
Hooi, J. K. Y., Lai, W. Y., Ng, W. K., Suen, M. M. Y., Underwood, F. E., Tanyingoh, D., Malfertheiner, P., Graham, D. Y., Wong, V. W. S., Wu, J. C. Y., Chan, F. K. L., Sung, J. J. Y., Kaplan, G. G., and Ng, S. C. (2017). Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology, 153(2), 420–429. https://doi.org/10.1053/j.gastro.2017.04.022
Hunt, R. H., Xiao, S. D., Megraud, F., Leon-Barua, R., Bazzoli, F., van der Merwe, S., Vaz Coelho, L. G., Fock, M., Fedail, S., Cohen, H., Malfertheiner, P., Vakil, N., Hamid, S., Goh, K. L., Wong, B. C. Y., Krabshuis, J., and Le Mair, A. (2011). Helicobacter pylori in developing countries. World Gastroenterology Organisation global guideline. Journal of Gastrointestinal and Liver Diseases, 20(3), 299–304. https://doi.org/10.1111/j.1751-2980.2011.00529.x
Isenberg, H. D. (2004). Clinical Microbiology Procedures Handbook (2nd ed.). ASM Press.
Kusters, J. G., van Vliet, A. H. M., and Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews, 19(3), 449–490. https://doi.org/10.1128/CMR.00054-05
Malaty, H. M. (2007). Epidemiology of Helicobacter pylori infection. Best Practice and Research Clinical Gastroenterology, 21(2), 205–214. https://doi.org/10.1016/j.bpg.2006.10.005
Marshall, B. J., and Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet, 1(8390), 1311–1315.
https://doi.org/10.1016/S0140-6736(84)91816-6
Mégraud, F., and Lehours, P. (2007). Helicobacter pylori detection and antimicrobial susceptibility testing. Clinical Microbiology Reviews, 20(2), 280–322. https://doi.org/10.1128/CMR.00033-06
Mentis, A., Lehours, P., and Mégraud, F. (2015). Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter, 20(Suppl 1), 1–7. https://doi.org/10.1111/hel.12250
Plummer, M., Franceschi, S., Vignat, J., Forman, D., and de Martel, C. (2015). Global burden of gastric cancer attributable to Helicobacter pylori. International Journal of Cancer, 136(2), 487–490. https://doi.org/10.1002/ijc.28999
Smith, S., Fowora, M., and Pellicano, R. (2019). Infections with Helicobacter pylori and challenges encountered in Africa. World Journal of Gastroenterology, 25(25), 3183–3195. https://doi.org/10.3748/wjg.v25.i25.3183
Suerbaum, S., and Michetti, P. (2002). Helicobacter pylori infection. New England Journal of Medicine, 347(15), 1175–1186. https://doi.org/10.1056/NEJMra020542
Tanih, N. F., Dube, C., Green, E., Enattah, N., Ndip, L. M., and Ndip, R. N. (2009). An African perspective on Helicobacter pylori: Prevalence of H. pylori infection and cagA and vacA genotypes in South Africa and Cameroon. Annals of Tropical Medicine and Parasitology, 103(3), 231–239. https://doi.org/10.1179/136485909X398140
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., and Valasek, M. A. (2016). Review article: The global emergence of Helicobacter pylori antibiotic resistance. Alimentary Pharmacology and Therapeutics, 43(4), 514–533. https://doi.org/10.1111/apt.13497
Yamaoka, Y. (2010). Mechanisms of disease: Helicobacter pylori virulence factors. Nature Reviews Gastroenterology and Hepatology, 7(11), 629–641. https://doi.org/10.1038/nrgastro.2010.154
Zamani, M., Ebrahimtabar, F., Zamani, V., Miller, W. H., Alizadeh-Navaei, R., Shokri-Shirvani, J., and Derakhshan, M. H. (2018). Systematic review with meta-analysis: The worldwide prevalence of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics, 47(7), 868–876. https://doi.org/10.1111/apt.14561
Citations
|
|
|
